Variant report
Variant | nsv946448 |
---|---|
Chromosome Location | chr1:159209579-159211067 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs534301430 | chr1:159209602-159209603 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs74125414 | chr1:159209708-159209709 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs6656286 | chr1:159209752-159209753 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs538310297 | chr1:159209817-159209818 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77209766 | chr1:159209845-159209846 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114272969 | chr1:159209865-159209866 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189105870 | chr1:159209888-159209889 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs555778196 | chr1:159209925-159209926 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553983716 | chr1:159209980-159209981 | Enhancers Weak transcription Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs574117707 | chr1:159210001-159210002 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367702599 | chr1:159210007-159210008 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541416278 | chr1:159210015-159210016 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs578155858 | chr1:159210063-159210064 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs545470679 | chr1:159210065-159210066 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181811087 | chr1:159210072-159210073 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4656673 | chr1:159210127-159210128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186501281 | chr1:159210173-159210174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542940752 | chr1:159210176-159210177 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs563058279 | chr1:159210226-159210227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs545947297 | chr1:159210254-159210255 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs112697915 | chr1:159210259-159210260 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189356897 | chr1:159210299-159210300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs181003931 | chr1:159210311-159210312 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs550971726 | chr1:159210355-159210356 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs373015473 | chr1:159210380-159210381 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs570867552 | chr1:159210424-159210425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs532083436 | chr1:159210449-159210450 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs28393074 | chr1:159210489-159210490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550402261 | chr1:159210501-159210502 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs562662287 | chr1:159210528-159210529 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531718466 | chr1:159210540-159210541 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570272972 | chr1:159210672-159210673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537233627 | chr1:159210722-159210723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527705573 | chr1:159210730-159210731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs138093861 | chr1:159210734-159210735 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs567981673 | chr1:159210801-159210802 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs16841928 | chr1:159210839-159210840 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs386635979 | chr1:159210840-159210841 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs114834217 | chr1:159210841-159210842 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186507224 | chr1:159210863-159210864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12095993 | chr1:159210880-159210881 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs575422182 | chr1:159210928-159210929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs35912026 | chr1:159210948-159210949 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542476675 | chr1:159210973-159210974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6660102 | chr1:159211064-159211065 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 17899364 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Type 2 diabetes | 19141583 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Systemic lupus erythematosus | 19220326 | CNVD |
Systemic lupus erythematosus | 19287148 | CNVD |
Glomerulonephritis | 19341492 | CNVD |
Systemic lupus erythematosus | 18559452 | CNVD |
Systemic autoimmune disease | 17597778 | CNVD |
Glomerulonephritis | 17008540 | CNVD |
Glomerulonephritis | 16482158 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Breast cancer | 21045282 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Cancer | 20164920 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:159199600-159211800 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr1:159208800-159209600 | Flanking Active TSS | GM12878-XiMat | blood |
3 | chr1:159208800-159210200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr1:159208800-159210600 | Enhancers | HMEC | breast |
5 | chr1:159209000-159209600 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr1:159209000-159210000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr1:159209000-159210600 | Enhancers | NHEK | skin |
8 | chr1:159209000-159211000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr1:159209200-159210200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr1:159209200-159210200 | Enhancers | HUVEC | blood vessel |
11 | chr1:159209200-159210400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr1:159209400-159210000 | Enhancers | Hela-S3 | cervix |
13 | chr1:159209600-159209800 | Enhancers | GM12878-XiMat | blood |
14 | chr1:159209800-159210000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
15 | chr1:159209800-159210000 | Flanking Active TSS | GM12878-XiMat | blood |
16 | chr1:159209800-159211000 | Enhancers | Primary monocytes fromperipheralblood | blood |
17 | chr1:159210000-159210400 | Enhancers | GM12878-XiMat | blood |
18 | chr1:159210200-159217000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |